Copy the page URI to the clipboard
Kale, Dinar and Huzair, Farah
(2014).
URL: http://www.schumpeter-conference.de/
Abstract
This paper examines the response of Indian firms to the emergence of a new disruptive market segment resulting from evolving biosimilar regulation and saturation of existing generics markets. Using novel analytical tools such as a technology–market capability matrix we show technological trajectories and heterogeneity in firm strategies employed by incumbent firms to compete in the biosimilars market. Analysis reveals that entry into emerging country markets and R&D collaborations formed core elements of experimentation with strategy.
Viewing alternatives
Download history
Item Actions
Export
About
- Item ORO ID
- 41045
- Item Type
- Conference or Workshop Item
- Keywords
- biosimilar; India; dynamic capabilities; pharmaceutical industry; biotechnology
- Academic Unit or School
-
Faculty of Arts and Social Sciences (FASS) > Social Sciences and Global Studies > Development
Faculty of Arts and Social Sciences (FASS) > Social Sciences and Global Studies
Faculty of Arts and Social Sciences (FASS)
Faculty of Science, Technology, Engineering and Mathematics (STEM) > Engineering and Innovation
Faculty of Science, Technology, Engineering and Mathematics (STEM) - Research Group
-
Innovation, Knowledge & Development research centre (IKD)
?? idii ??
Institute for Innovation Generation in the Life Sciences (Innogen) - Copyright Holders
- © 2014 The Authors
- Related URLs
- Depositing User
- Dinar Kale